- €9.34bn
- €12.52bn
- €5.06bn
- 58
- 39
- 40
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,049 | 1,621 | 2,204 | 4,224 | 5,056 |
Cost of Revenue | |||||
Gross Profit | 3,942 | 1,572 | 2,150 | 4,142 | 4,930 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,375 | 3,244 | 1,883 | 3,714 | 4,321 |
Operating Profit | 674 | -1,623 | 321 | 510 | 735 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 602 | -2,309 | -56 | 459 | 679 |
Provision for Income Taxes | |||||
Net Income After Taxes | 464 | -2,247 | 13 | 383 | 640 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 463 | -1,988 | 84 | 401 | 633 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 422 | -2,021 | 49 | 367 | 588 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.986 | -6.31 | -1.47 | 1.03 | 2.14 |
Dividends per Share |